Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate
Youssef Bakri, Sandrine Sarrazin, Ulrich P. Mayer et al. · Blood · 2004
Macrophages and myeloid dendritic cells (DCs) represent alternative differentiation options of bone marrow progenitors and blood monocytes. This choice profoundly influences the immune response under normal and pathological conditions, but the underlying transcriptional events remain unresolved. Here, we show that experimental activation of the transcription factors PU.1 and MafB in transformed chicken myeloid progenitors triggered alternative DC or macrophage fate, respectively. PU.1 activation also was instructive for DC fate in the absence of cytokines in human HL-60 cell-derived myeloid progenitor and monocyte clones. Differentiation of normal human monocytes to DCs led to a rapid increase of PU.1 to high levels that preceded phenotypic changes, but no MafB expression, whereas monocyte-derived macrophages expressed MafB and only moderate levels of PU.1. DCs inducing levels of PU.1 inhibited MafB expression in monocytes, which appeared to be required for DC specification, since constitutive MafB expression inhibited DC differentiation. Consistent with this, PU.1 directly bound to MafB, inhibited its transcriptional activity in macrophages, and repressed its ability to induce macrophage differentiation in chicken myeloid progenitors. We propose that high PU.1 activity favors DCs at the expense of macrophage fate by inhibiting expression and activity of the macrophage factor MafB.
Cited by 187 works. doi:10.1182/blood-2004-04-1448
Authors
- Youssef Bakri
- Sandrine Sarrazin
- Ulrich P. Mayer
- Silke Tillmanns
- Claus Nerlov
- Annie Boned
- Michael H. Sieweke
References
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
- Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
- Requirement of Transcription Factor PU.1 in the Development of Multiple Hematopoietic Lineages
- Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In Vivo
- Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus
- Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.
- Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.
- Osteopetrosis in mice lacking haematopoietic transcription factor PU.1
- Stepwise Reprogramming of B Cells into Macrophages
- Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor